X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Holly Campbell

Holly Campbell Holly Campbell is a deputy vice president of public affairs at PhRMA focusing on the cost and value of medicines. Prior to joining PhRMA, Holly worked for large and small public relations firms where she provided strategic communications counsel, media relations and partnership expertise to health care and pharmaceutical clients. In her free time, she enjoys taking barre classes, trying new restaurants and spending time with Boss and Poppy, her rescue pups.

Recent Posts

Spending on medicines grew less than one percent in 2017

By Holly Campbell  |    April 19, 2018
Last year, a record number of new treatments and cures that are transforming care for patients fighting debilitating diseases like cancer, hepatitis C, high cholesterol and more were approved by...   Read More

New Let’s Talk About Cost ads highlight how copay accumulator programs could leave patients financially exposed

By Holly Campbell  |    March 27, 2018
Today, as part of the Let’s Talk About Cost campaign, PhRMA unveiled new advertisements highlighting how the use of copay accumulator programs by insurance companies and other middlemen could...   Read More

Video: How does the supply chain shape brand-name medicine prices?

By Holly Campbell  |    March 19, 2018
A medicine’s path from the biopharmaceutical company to the patient is complex and involves many entities across the biopharmaceutical supply chain. In fact, more than one-third of the initial...   Read More

4 Things to know about the IQVIA 2018 and Beyond: Outlook and Turning Points report

By Holly Campbell  |    March 13, 2018
We continue to see a deluge of data from government actuaries and pharmacy benefit managers (PBMs) showing a dramatic slowdown in medicine spending growth. Most recently, the IQVIA Institute for...   Read More

ICYMI – Two PBM reports show dramatic slowdown in medicine spending growth

By Holly Campbell  |    March 2, 2018
Newly released pharmacy benefit manager (PBM) data show medicine spending is growing at the slowest rate in years. After accounting for discounts and rebates negotiated with biopharmaceutical...   Read More

Copay coupons can help ease patients’ out-of-pocket costs

By Holly Campbell  |    February 16, 2018
Each year, middlemen, like pharmacy benefit managers (PBMs) and insurers, shift more of the costs of health care to patients. Ensuring patients have affordable access to their medicines is the top...   Read More

PhRMA launches new consumer-facing Let’s Talk About Cost website

By Holly Campbell  |    January 24, 2018
Today, as part of the Let’s Talk About Cost campaign, PhRMA launched LetsTalkAboutCost.org, a national consumer-facing website to provide consumers with easy-to-understand information about the...   Read More

NHE Data: Medicine spending grew just 1.3 percent in 2016

By Holly Campbell  |    December 12, 2017
According to new data from the National Health Expenditures (NHE), retail medicine spending grew just 1.3 percent in 2016, down from 9 percent in 2015. To put that in context, total spending for...   Read More

The Washington Post retracts PhRMA claim in opioid story

By Holly Campbell  |    October 18, 2017
Earlier this week, The Washington Post falsely claimed that the PhRMA supported the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and spent $40 million advocating for its...   Read More

Excerpts from testimony by PhRMA’s Lori Reilly

By Holly Campbell  |    October 17, 2017
Today, Lori Reilly, executive vice president for policy, research and membership at the Pharmaceutical Research and Manufacturers of America (PhRMA), testified at the U.S. Senate Committee on...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates